NEU 2.50% $15.59 neuren pharmaceuticals limited

new trial Trofinetide, page-19

  1. 190 Posts.
    lightbulb Created with Sketch. 66
    I understand your logic Investie.
    I think the problem is people might continue if there's some perceived benefit (even grasping at hopeful straws) but in reality it's a placebo beneficial effect (not really due the properties of the 'drug' itself). This is why the statistical analyses are important. Of course I want the trials etc to succeed.

    Not professional advice : please do your own DD

 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.